Long-term survival of patients with bladder tumours: The significance of risk factors

British Journal of Urology

Volumn 82, Issue 5, 1998, Pages 667-672

  Zieger, K ^a,b   Wolf, H ^a   Olsen, P R ^a   Hojgaard K ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b NONE   (Denmark)

Author keywords

Bladder cancer; Grade; Invasive disease; Long term outcome; Prognosis; Stage; Survival

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER BIOPSY; BLADDER CANCER; CANCER GRADING; CANCER SURVIVAL; CAUSE OF DEATH; CYTOLOGY; DISEASE COURSE; DYSPLASIA; ENDOSCOPY; FEMALE; HISTOLOGY; HUMAN; LAMINA PROPRIA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; TUMOR VOLUME; URINE CYTOLOGY;

ADULT; AGED; CAUSE OF DEATH; DENMARK; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 0031793213     PISSN: 00071331     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.1998.00848.x     Document Type: Article

References (24)

1. Anderström C, Johansson S. Nilsson S. The significance of lamina propria invasion on the prognosis of patients with bladder tumours. J Ural 1980: 124: 23-6
2. Spruck CH, Ohneseit PF, Gonzales-Zulueta M et al. Two molecular pathways to transitional cell carcinoma of the bladder. Cancer Res 1994; 54: 784-8
3. Olsen LH, Overgaard S, Frederiksen P et al. The reliability of staging and grading of bladder tumours. Impact of misinformation on the pathologist's diagnosis. Scand J Urol Nephrol 1993; 27: 349-53
4. Freeman JA, Esrig DE. Stein JP et al Radical cystectomy for high risk patients in the era of orthotopic urinary construction. Cancer 1995; 76: 833-9
5. Ooms ECM, Anderson WAD, Alons CD, Boon ME. Veldhuizen RW. Analysis of performance of pathologists in the grading of bladder tumors. Hum Pathol 198 3; 14: 140-3
6. Wolf H, H0jgaard K. Urothelial dysplasia in random mucosal biopsies from patients with bladder tumours. Scand JUrol Nephrol 1980: 14: 37-41
7. Heney NM, Ahmed S, Flanagan MJ, Frable W, Corder MP, Hafermann MD et al. Superficial bladder cancer: Progression and recurrence. J Urol 1983; 130: 1083-6
8. Fitzpatrick JM, West AB, Butler MR, Lane V, O'Flynn JD. Superficial bladder tumours (stage pTa, grades 1 and 2): the importance of recurrence pattern following initial resection. J Urol 1986; 135: 920-2
9. Olsen PR, Wolf H, Schrader T, Fischer A, Ffojgaard K. Urothelial atypia and survival rate of 500 unselected patients with primary transitional-cell tumour of the urinary bladder. Scand JUrol Nephrol 1988; 22: 257-63
10. Wolf H, Hojgaard K. Urothelial dysplasia concomitant with bladder tumours as a determinant factor for future new occurrences. Lancet 1983; ii: 134-6
11. Wolf H, Olsen PR, Fischer A, Hojgaard K. Urothelial atypia concomitant with primary bladder tumour. Stand J Urol Nephrol 1987; 21: 33-8
12. Harmer MH. TNM classification of malignant tumours, 3rd edn. Geneva: UICC, 1978
13. Bergkvist A, Ljungkvist A, Moberger G. Classification of bladder tumours based on a cellular pattern. Ada Chir Scand 1965: 130: 371-8
14. Cox DR. Regression models and life tables. J Roy Stat Soc B 1972; 34: 187-220
15. Cutler SJ, Heney NM, Friedell GH. Longitudinal study of patients with bladder cancer: factors associated with disease recurrence and progression. In Bonney W, Prout GR, eds, Bladder Cancer. AUA Monographs Vol. 1. Baltimore: Williams and Wilkins. 1982: 35-47
16. Abel PD, Hall RR, Williams G. Should pt1 transitional cell cancers of the bladder still be classified as superficial? Br JUrol 1988: 62: 235-9
17. Kiemeney LALM, Witjes JA, Heijbroek RP et al. Should random urethral biopsies be taken from patients with primary superficial bladder cancer? A decision analysis. Br JUrol 1994; 73: 164-71
18. Messing EM, Young TB, Hunt VB et al. Comparison of bladder cancer outcome in men undergoing hematuria home screening versus those with standard clinical presentations. Urology 1995; 45: 387-97
19. Cookson MS, Sarosdy MF. Management of stage t1 superficial bladder cancer with intravesical bacillus Calmette-Guerin therapy. J Urol 1992; 148: 797-801
20. Abel PD. Follow-up of patients with 'superficial' transitional cell carcinoma of the bladder: the case for a change in policy. BrJUrol 1993; 72: 135-42
21. Weinstein RS. Miller AW 3rd, Pauli BU. Carcinoma in situ: comments on the pathobiology of a paradox. Urol Clin North Am 1980; 7: 523-31
22. Prout GR. Barton BA, Griffin PP, Friedell GH. Treated history of noninvasive grade 1 transitional cell carcinoma. J Urol 1992: 148: 1413-9
23. Harving N, Wolf H, Meisen F. Positive urinary cytology after tumour resection: an indicator for concomitant carcinoma in situ. J Urol 1988; 140: 495-7
24. Wolf H. Iversen HG, Olsen PR, Schröder T. Transurethral surgery in the treatment of invasive bladder cancer (t1 and T2). Scand JUrol Nephrol 1987; 104 (Suppl): 27-32